TRIAL DATA
Phase III Trial Compares Total Neoadjuvant Therapy Approaches in High-Risk Rectal CancerA multicenter, randomized phase III trial evaluated total neoadjuvant therapy with long-course radiotherapy versus chemoradiotherapy in patients with high-risk locally advanced rectal cancer. (Journal of Clinical Oncology)